Heat Shock Protein 70 as a Biomarker of Clinical Outcomes After STEMI
- 6 January 2020
- journal article
- letter
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 75 (1), 122-124
- https://doi.org/10.1016/j.jacc.2019.10.044
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Heat shock protein 70: A promising therapeutic target for myocardial ischemia–reperfusion injuryJournal of Cellular Physiology, 2018
- Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion InjuryJournal of the American College of Cardiology, 2017
- Heat shock proteins are no DAMPs, rather 'DAMPERs'Nature Reviews Immunology, 2011
- Extracellular Heat Shock Protein 70 Induces Cardiomyocyte Inflammation and Contractile Dysfunction via TLR2Circulation Journal, 2011
- Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarctionHeart, 2005